Daewon Pharmaceutical Co., Ltd. (003220.KS) KSC

8,220.00

-120(-1.44%)

Updated at June 02 03:30PM

Currency In KRW

Daewon Pharmaceutical Co., Ltd.

Address

386 Cheonhodae-ro

Seoul,

Korea (the Republic of)

Phone

82 2 2204 7000

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Employees

1260

First IPO Date

September 29, 2005

Key Executives

NameTitlePayYear Born
Seung-Ryel BaekVice Chairman & CEO01959
Jonathan In BaekCEO, President & Director0N/A

Description

Daewon Pharmaceutical Co., Ltd., a pharmaceutical company, produces and sells medicine and medical supplies in South Korea. It offers various medicines for circulatory, respiratory, antibiotic, chemotherapy, and psychoneurosis uses. The company's principal products include Oramin-F Soft Cap, a multivitamin product; Pelubi Tablet, a NSAID product for pain relief; Freefol-MCT Inj., a microemulsion propofol for the anti-exogenous infectious bacteria; Megex-I Susp, a medicine that supplements subalimentation of cancer patients; Trigel Susp, a therapy for gastritis and duodenal ulcer; and Renamezin Cap, a spherical carbonaceous adsorbent for chronic kidney disease. It also exports its products to approximately 45 countries primarily in Asia, Central and South America, the Middle East, etc. The company was founded in 1958 and is headquartered in Seoul, South Korea.